Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer. Ali M, Koo K, Chang D, Chan P, et al. Radiat Oncol 2024;19:23.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ali M, Koo K, Chang D, Chan P, et al. Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer. Radiat Oncol 2024;19:23.
PMID: 38355495